InDevR
Life science company developing advanced characterization assays for vaccines, biologics, and infectious disease diagnostics, including multiplexed microarray platforms.
Notes
InDevR is a life science company developing advanced analytical tools for characterizing vaccines and biologics, as well as infectious disease diagnostics. The company's technology platforms include multiplexed microarray assays that can rapidly measure multiple analytes simultaneously.
Based in Boulder, Colorado, InDevR serves pharmaceutical companies, government agencies, and research institutions with products for vaccine quality control, influenza surveillance, and other applications. The company's VaxArray and other platforms provide faster, more accurate testing compared to traditional methods.
InDevR's products have been used for influenza vaccine potency testing, helping manufacturers and regulators ensure vaccine quality and efficacy.
Team
- Kathy Rowlen, Ph.D. - Founder & Chief Scientific Officer (University of Colorado professor)
- Experienced team in analytical chemistry and diagnostics
Additional Research Findings
- Founded in 2003 in Boulder, Colorado
- Spun out from University of Colorado research
- VaxArray platform for vaccine characterization
- Multiplexed microarray technology
- Influenza vaccine potency testing
- Serves pharma, government, and research customers
- Products used by major vaccine manufacturers
- FDA-recognized testing methods
- Applications in pandemic preparedness
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |